CKD-828 Drug Interaction Study (S-amlodipine)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Healthy Male Volunteers
Interventions
DRUG

S-amlodipine 5mg,Telmisartan 80mg

S-amlodipine 5mg and Telmisartan 80mg, Oral, Once a day, for 9 days + Wash out (19 days)

DRUG

S-amlodipine 5mg

S-amlodipine 5mg, Oral, Once a day, for 9 days + Wash out(19 days)

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT01356043 - CKD-828 Drug Interaction Study (S-amlodipine) | Biotech Hunter | Biotech Hunter